Company IntegraGen

Stocks

ALINT

FR0010908723

Biotechnology & Medical Research

Real-time Euronext Paris 11:55:00 2026-11-02 EST			5-day change	1st Jan Change
0.0750 ^EUR	0.00%		-26.47%	-43.61%

10-29	IntegraGen SA Reports Earnings Results for the Half Year Ended June 30, 2026	CI
10-12	ABL Texcell Diagnostics to Acquire French Biotech Company IntegraGen	MT

Business description: IntegraGen

IntegraGen specializes in researching and identifying genetic biomarkers, primarily in the field of oncology. The group offers high-speed genotyping services, medium-speed genotyping services, and ultra-high-speed sequencing services for academic research institutions and pharmaceutical groups.

France accounts for 84.4% of net sales.

Number of employees: 37

Sales by Activity: IntegraGen

Fiscal Period: December	2019 (EUR)	2020 (EUR)
Services	8.28M	-

See all business segments

Geographical breakdown of sales: IntegraGen

Fiscal Period: December	2019 (EUR)	2020 (EUR)
Export	350K	-
France	7.93M	-

See all geographic segments

Executive Committee: IntegraGen

Manager	Title	Age	Since
Bernard Courtieu CEO	Chief Executive Officer	62	2009-11-08
Virginie de Coster DFI	Director of Finance/CFO	-	2022-12-31
Berengere Genin COO	Chief Operating Officer	-	2023-12-31
Jean-Pol Detiffe PRN	Corporate Officer/Principal	53	2020-12-31
Béatrice Cosperec LAW	General Counsel	-	2018-12-31

See INTEGRAGEN governance

Composition of the Board of Directors: IntegraGen

Director	Title	Age	Since
Bernard Courtieu CHM	Chairman	62	2011-09-21
Jean-Pol Detiffe BRD	Director/Board Member	53	2020-12-31
François Blondel BRD	Director/Board Member	63	2023-12-30
Charles-Andrew Brouwers CHM	Chairman	-	2023-06-22
François Fontaine BRD	Director/Board Member	-	2023-07-22

Composition of the Board of Directors

Company details: IntegraGen

IntegraGen SA

5, rue de Henri Desbruères

91000, Evry

+33 1 60 91 09 00

http://www.integragen.com

Bio Diagnostics & Testing

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
INTEGRAGEN	0.00%	-26.47%	-50.33%	-92.33%	554K
WUXI APPTEC CO., LTD.	-2.43%	-7.34%	+36.10%	+58.44%	62.23B
ARGENX SE	+0.61%	+0.77%	+11.13%	+69.42%	54.92B
LONZA GROUP AG	+0.80%	+2.74%	+21.14%	+98.48%	55.26B
IQVIA HOLDINGS INC.	+1.53%	-3.52%	+22.49%	+32.85%	42.59B
BEONE MEDICINES AG	-1.54%	-2.38%	+14.58%	+94.43%	41.08B
REVOLUTION MEDICINES, INC.	+3.16%	+4.51%	+228.04%	+778.27%	40.33B
GENMAB A/S	+0.57%	+24.09%	+99.46%	+84.11%	33.12B
CELLTRION, INC.	-1.09%	-0.05%	+13.55%	+45.35%	32.61B
INSMED INCORPORATED	-4.24%	+10.81%	-43.50%	+323.44%	23.98B
Average	-0.21%	+0.58%	+35.27%	+149.25%	38.61B
Weighted average by Cap.	-0.13%	+2.11%	+45.25%	+159.48%